ICMR's 'Medical Innovations Patent Mitra' event transfers 41 public health technologies to industry
On 25 May 2026 ICMR held 'Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect' in New Delhi, transferring 41 public health technologies to industry, including the first-ever transfer of inactivated KFD and Chandipura virus biomaterials.
Summary
The Indian Council of Medical Research, under the Department of Health Research, organised 'Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect', described as India's largest biomedical innovation and technology transfer event, at the Manekshaw Centre, New Delhi. ICMR launched an innovator–industry platform and transferred 41 public health technologies to industry. India also saw the first-ever transfer of inactivated Kyasanur Forest Disease (KFD) and Chandipura virus biomaterials to industry partners to support research and vaccine manufacturing. MoS Prataprao Jadhav, NITI Aayog Member Dr Gobardhan Das and ICMR DG Dr Rajiv Bahl spoke at the event.
Key facts
- Event
- Medical Innovations Patent Mitra: I2I Connect, 25 May 2026
- Venue
- Manekshaw Centre, New Delhi
- Organiser
- ICMR (Department of Health Research)
- Technologies transferred
- 41 public health technologies
- First-ever
- Transfer of inactivated KFD and Chandipura virus biomaterials to industry
- Speakers
- MoS Prataprao Jadhav; NITI Aayog Member Gobardhan Das; ICMR DG Rajiv Bahl
Practice MCQs 2 questions
How many public health technologies did ICMR transfer to industry at the 'Medical Innovations Patent Mitra: I2I Connect' event in May 2026?
Show answer
Correct answer: B — 41
ICMR transferred 41 public health technologies to industry at the event.
The May 2026 ICMR event saw India's first-ever transfer to industry of inactivated biomaterials of which two viruses?
Show answer
Correct answer: D — Kyasanur Forest Disease and Chandipura
India witnessed the first-ever transfer of inactivated KFD (Kyasanur Forest Disease) and Chandipura virus biomaterials to industry partners.